Amgen
Matthew Gray has extensive experience in value and access within the biopharmaceutical industry, currently serving as Executive Director of Value and Access at Amgen since August 2022. Prior roles include Executive Director at Biogen from January 2016 to March 2022, where responsibilities encompassed global pricing and payer access solutions, as well as senior-level positions in contracts and pricing. Matthew's career also includes leadership at Keryx Biopharmaceuticals, EMD Serono, Inc., and CVS Health, spanning finance and managed markets. Educational credentials include a BBA in Finance from the University of Massachusetts Amherst, obtained between 1986 and 1991.
This person is not in any teams
This person is not in any offices
Amgen
280 followers
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.